Acknowledgement
본 연구는 2020년 대웅재단(DY20109C), 정부(과학기술정보통신부, 산업통산자원부, 보건복지부, 식품의약품안전처)의 재원으로 범부처 전주기의료기기연구개발사업단(과제번호: RS-2020-KD000246), 2021년 전라남도와 전남테크노파크의 지역수요맞춤형 연구개발사업의 지원을 받아 수행된 연구이다.
References
- S. G. Raja, B, Bendetto, C. D. Ilseley, and M. Amrani, Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis, Int. J. Cardiol., 189, 153-158 (2015). https://doi.org/10.1016/j.ijcard.2015.04.059
- S. Kuramitsu, S. Sonoda, K. Ando, H. Otake, M. Natsuaki, R. Anai, Y. Honda, K. Kadota, Y. Kobayashi, and T. Kimura, Drug-eluting stent thrombosis: Current and future perspectives, Cardiovasc. Interv. Ther., 36, 158-168 (2021). https://doi.org/10.1007/s12928-021-00754-x
- J. Torrado, L. Buckley, A. Duran, P. Trujillo, S. Toldo, J. V. Raleigh, A. Abbate, G. Biondi-Zoccai, and L. A. Guzman, Restenosis, stent thrombosis, and bleeding complications: Navigating between scylla and charybdis, J. Am. Coll. Cardiol., 71, 1676-1695 (2018). https://doi.org/10.1016/j.jacc.2018.02.023
- R. V. Jeger, S. Eccleshall, W. A. W. Ahmad, J. Ge, T. C. Poerner, E. S. Shin, F. Alfonso, A. Latib, P. J. Ong, T. T. Rissanen, J. Saucedo, B. Scheller, and F. X. Kleber, Drug-coated balloons for coronary artery disease: Third report of the International DCB Consensus Group, JACC Cardiovasc. Interv., 13, 1391-1402 (2020). https://doi.org/10.1016/j.jcin.2020.02.043
- R. V. Jeger, A. A. Farah, M. A. Ohlow, N. Manger, S. Mobius-Winkler, D. Weilenmann, G. Stachel, S. Markovic, G. Leibundgut, P. Rickenbacher, S. Osswald, M. Cattaneo, N. Gilgen, C. Kaiser, and B. Scheller, Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial, Lancet, 396, 1504-1510 (2020). https://doi.org/10.1016/s0140-6736(20)32173-5
- R. A. Byrne, M. Joner, F. Alfonso, and A. Kastrati, Drug-coated balloon therapy in coronary and peripheral artery disease, Nat. Rev. Cardiol., 11, 13-23 (2014). https://doi.org/10.1038/nrcardio.2013.165
- F. X. Kleber, H. Rittger, K. Bonaventura, U. Zeymer, J. Wohrle, R. Jeger, B. Levenson, S. Mobius-Winkler, L. Bruch, D. Fischer, C. Hengstenberg, T. Porner, D. Mathey, and B. Scheller, Drug-coated balloons for treatment of coronary artery disease: Updated recommendations from a consensus group, Clin. Res. Cardiol., 102, 785-797 (2013). https://doi.org/10.1007/s00392-013-0609-7
- Transparency Market Research, Drug Eluting Balloon Market (Product - Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon; Drug Coating Technology - Paccocath, FreePac, TransPax, EnduraCoat) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026, New York, USA (2022).
- I. Rykowska, I. Nowak, and R. Nowak, Drug-eluting stents and balloons-materials, structure designs, and coating techniques: A review, Molecules, 25, 4624 (2020). https://doi.org/10.3390/molecules25204624
- S. Bose. S. S. Keller, T. S. Alstrom, A. Boisen, and K. Almdal, Process optimization of ultrasonic spray coating of polymer films, Langmuir, 29, 6911-6919 (2013). https://doi.org/10.1021/la4010246
- J. Ju, Y. Yamagata, and T. Higuchi, Thin-film fabrication method for organic light-emitting diodes using electrospray deposition, Adv. Mater., 21, 4343-4347 (2009). https://doi.org/10.1002/adma.200900444
- M. Bukka, P. J. Rednam, and M. Sinha, Drug-eluting ballon: Design, technology and clinical aspects, Biomed. Mater., 13, 032001 (2018). https://doi.org/10.1088/1748-605X/aaa0aa
- S. Sharma, N. Kukreja, C. Christopoulos and D. A. Gorog, Drug-eluting balloon: New tool in the box, Expert Rev. Med. Devices, 7, 381-388 (2014). https://doi.org/10.1586/erd.10.5
- T. Shazly, W. M. Torees, E. A. Secemsky, C. C. Chitalia, F. A. Jaffer, V. B. Kolachalam, Understudied factors in drug-coated balloon design and evaluation: A biophysical perspective, Bioeng. Transl. Med., Doi: 10.1002/btm2.10370.